Spencer Stiles Will Become Stryker CEO in January

The medical technology firm will transition Kevin Lobo to Executive Chair on January 1, 2027.

Updated on Oct. 6, 2026 in People

Isometric editorial illustration featuring a precision-engineered surgical instrument component on a platform, representing medical technology corporate governance. — Stryker has announced that Spencer Stiles will succeed Kevin Lobo as Chief Executive Officer on January 1, 2027, as part of a long-term succession plan. AI Illustration. Upload story photo >

Live Poll

Do you believe changes in top corporate leadership generally improve services for customers?

Stryker has announced that Spencer Stiles will succeed Kevin Lobo as the company's Chief Executive Officer on January 1, 2027. Lobo will transition from his current role to serve as Executive Chair of the Board starting on that date.

Why it matters

The leadership change concludes a long-term succession planning process overseen by the Board of Directors. It marks a significant shift in corporate governance for the Portage-based medical technology giant.

During Kevin Lobo's tenure, Stryker completed more than 60 acquisitions and grew annual net sales from $8.7 billion in 2012 to over $26 billion in 2026. The firm reports that its products impact 150 million patients annually.

The players

Spencer Stiles

He is the current President and COO of Stryker who will assume the role of Chief Executive Officer on January 1, 2027.

Kevin Lobo

He is the outgoing CEO of Stryker who will transition to the position of Executive Chair of the Board on January 1, 2027.

Stryker

It is a medical technology company headquartered in Portage, Michigan, that provides products and services in orthopaedics, medical and surgical, and neurotechnology.

The details

Spencer Stiles, who joined Stryker in 1999 and became President and COO in January 2026, will also join the Board of Directors. Kevin Lobo, who joined the company in 2011, served as CEO for 14 years and Chair of the Board since 2014.

Spencer Stiles joined the company in 1999.
Kevin Lobo joined Stryker in 2011.
Spencer Stiles became President and COO in January 2026.
Stryker announced the leadership succession on October 6, 2026.
The leadership transition becomes effective January 1, 2027.

Market Landscape

This transition follows the 14-year period of growth and acquisition-driven expansion established during the 2012 appointment of Kevin Lobo as CEO. It signals a move to maintain institutional continuity while repositioning the company for its next phase of global expansion.

The transition represents an internal change in governance and is not expected to cause immediate disruptions to product availability or pricing for healthcare providers. Patients and clinical customers can expect continued operations as the firm completes its planned leadership handover.

The takeaway

The move underscores the importance of long-term succession planning in maintaining corporate stability during major leadership handovers. Investors and partners should monitor the company's upcoming quarterly filings for any shifts in long-term operational strategy under the incoming CEO.